Lenacapavir for HIV Prevention in South Africa
South Africa will introduce lenacapavir for HIV prevention in 2026, offering a new hope in the fight against HIV.
Twice-Yearly HIV Jab: Activists Call for Lower Prices
Explore the revolutionary Twice-Yearly HIV Jab, a potential game-changer in HIV prevention that raises important affordability questions.
Global fund affirms commitment to lenacapavir rollout
The Global Fund for HIV, TB, and Malaria reaffirms its commitment to introducing the twice-yearly HIV prevention jab, lenacapavir, in underprivileged countries.